RIPK3 and cancer: One of these mutations for RIPK3, V458M, resides within the tetra-peptide core of the RHIM and is likely to disrupt RHIM-mediated protein interaction and signaling.5 In addition, missense mutations in the kinase domain of RIPK1 that might alter its signaling function have also been found in different types of cancers.